603368 柳药集团
2026/06 - 中期2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)4.7009.18212.00513.50012.276
总资产报酬率 ROA (%)1.7603.3304.1274.3834.069
投入资产回报率 ROIC (%)2.5484.7315.6255.9755.601

边际利润分析
销售毛利率 (%)10.43511.04711.36611.88911.505
营业利润率 (%)4.1254.2174.7385.0154.672
息税前利润/营业总收入 (%)4.9835.1985.8466.2125.829
净利润/营业总收入 (%)3.5283.4434.0964.3563.984

收益指标分析
经营活动净收益/利润总额(%)102.265104.655101.247104.038104.008
价值变动净收益/利润总额(%)0.260-0.006-0.009-0.0680.832
营业外收支净额/利润总额(%)-2.078-1.430-0.046-0.0290.038

偿债能力分析
流动比率 (X)1.6011.5081.5701.4911.489
速动比率 (X)1.3151.2641.3471.2921.262
资产负债率 (%)60.25561.84362.68364.96165.791
带息债务/全部投入资本 (%)42.21543.27047.51952.51452.370
股东权益/带息债务 (%)129.572124.211104.03284.17184.625
股东权益/负债合计 (%)63.46859.32857.18950.53348.760
利息保障倍数 (X)5.2894.9935.2655.1835.044

营运能力分析
应收账款周转天数 (天)174.588180.960178.818165.680151.143
存货周转天数 (天)58.65454.37247.44346.80645.557